427
12 Consensus Drug Design Using IT Microcosm
62. Morphy R, Kay C, Rankovic Z (2004) From magic bullets to designed multiple ligands. Drug
Discov Today 9(15):641–651
63. No BI, Zotov YuL, Shishkin EV et al (2001) Adamantyl-containing derivatives of imidic acids with predicted high psychotropic, antiviral and antifungal activity. In: Proceedings of the
IX International scientific conference “Chemistry and technology of carcass compounds”,
VolgGTU, Volgograd, 5–7 June 2001, pp 194–195
64. No BI, Vassiliev PM, Zotov YuL et al (2003) Computer design and directed synthesis of
adamantyl-containing compounds, highly effective additives to polymer compositions. Int
Polym Sci Technol 30(4):27–32
65. Opitz D, Maclin R (1999) Popular ensemble methods: an empirical study. J Artif Intell Res
11:169–198
66. Oprisiu I, Varlamova E, Muratov E et al (2012) QSPR approach to predict nonadditive properties of mixtures. Application to bubble point temperatures of binary mixtures of liquids.
Mol Inf, 31(6–7):491–502
67. Orlov VV, Vassiliev PM, Derbisher VE (1999) Computer system for estimation of carcinogenic risk of chemical production. In: Proceeding of the 4th Russian scientific and practical conference with international participation “Novelties in Envionmentalism and Safety of
Living”, Saint Petersburg, 16–18 June 1999, p 212
68. Orlov VV, Derbisher VE, Zotov YuL et al (2003) Diagnostics of possible activity of adamantane derivatives in polymer compositions by molecular design. Khimicheskaya promishlennost 80(2):46–55
69. Petrov VI, Spasov AA, Anisimova VA et al (2003) The development and clinical testing of
antiarrhythmia drugs of a new chemical class. Vestn Ross Akad Med Nauk 12:15–20
70. Poroikov V, Lagunin A, Filimonov D (2005) PASS: prediction of biological activity spectra for substances. In: Helma C (ed) Predictive toxicology. Taylor & Francis, New-York,
pp 459–478
71. Preston Mason R (2012) Pleiotropic effects of calcium channel blockers. Curr Hypertens Rep
14(4):293–303
72. Puzyn T, Leszczynski J, Cronin MTD (eds) (2010) Recent advances in QSAR studies: methods and applications. Challenges and advances in computational chemistry and physics,
vol 8. Springer Science+Business Media BV, Dordrecht
73. Radchenko EV, Palyulin VA, Zefirov NS (2008) Molecular field topology analysis in drug
design and virtual screening. In:Varnek A, Tropsha A (eds) Chemoinformatics approaches to
virtual screening. Royal Society of Chemistry, Cambridge, pp 150–181
74. Samokhina MP, Vassiliev PM, Chepljaeva NI (2007) QSAR-modeling of synergism between
active compounds of Gymnema sylvestris extract. In: Proceeding of the III Congress of
Pharmacologists of Russia “Pharmacology—practical health”, Saint Petersburg, 23–27 Sept
2007. Psycopharmacol biol narcol 7:1936
75. Samokhina MP, Vassiliev PM, Chepljaeva NI (2008) Experimental study of hypoglycemic
activity of Gymnema sylvestris extract and computer modeling of its components synergism.
In: Collection of scientific papers “Development, research and marketing of new pharmaceutical products”, PyatGFA, Pyatigorsk, p 490
76. Shanmugasundaram ER, Gopinath KL, Radha Shanmugasundaram K et al (1990) Possible
regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol 30(3):265–279
77. Siebert CD, HaÑ’nsicke A, Nagel T (2008) Stereochemical comparison of nebivolol with
other b-blockers. Chirality 20(2):103–109
78. Simonov AM, Kovalev GV, Anisimova VA et al (1996) Antiarrhythmic agent. Patent RU
2068261, 27 Oct 1996
79. Spasov AA, Chernikov MV, Vassiliev PM et al (2007) Histamine receptors (molecular biological and pharmacological aspects). Izd-vo VolgGMU, Volgograd
80. Spasov AA, Vassiliev PM, Grechko OY et al (2010) In silico screening of condensed azoles
derivatives with high pharmacological activity. In: Proceedings of the 2nd International congress EurasiaBio-2010, Moscow, 13–15 Apr 2010, pp 372–374
12 Consensus Drug Design Using IT Microcosm
62. Morphy R, Kay C, Rankovic Z (2004) From magic bullets to designed multiple ligands. Drug
Discov Today 9(15):641–651
63. No BI, Zotov YuL, Shishkin EV et al (2001) Adamantyl-containing derivatives of imidic acids with predicted high psychotropic, antiviral and antifungal activity. In: Proceedings of the
IX International scientific conference “Chemistry and technology of carcass compounds”,
VolgGTU, Volgograd, 5–7 June 2001, pp 194–195
64. No BI, Vassiliev PM, Zotov YuL et al (2003) Computer design and directed synthesis of
adamantyl-containing compounds, highly effective additives to polymer compositions. Int
Polym Sci Technol 30(4):27–32
65. Opitz D, Maclin R (1999) Popular ensemble methods: an empirical study. J Artif Intell Res
11:169–198
66. Oprisiu I, Varlamova E, Muratov E et al (2012) QSPR approach to predict nonadditive properties of mixtures. Application to bubble point temperatures of binary mixtures of liquids.
Mol Inf, 31(6–7):491–502
67. Orlov VV, Vassiliev PM, Derbisher VE (1999) Computer system for estimation of carcinogenic risk of chemical production. In: Proceeding of the 4th Russian scientific and practical conference with international participation “Novelties in Envionmentalism and Safety of
Living”, Saint Petersburg, 16–18 June 1999, p 212
68. Orlov VV, Derbisher VE, Zotov YuL et al (2003) Diagnostics of possible activity of adamantane derivatives in polymer compositions by molecular design. Khimicheskaya promishlennost 80(2):46–55
69. Petrov VI, Spasov AA, Anisimova VA et al (2003) The development and clinical testing of
antiarrhythmia drugs of a new chemical class. Vestn Ross Akad Med Nauk 12:15–20
70. Poroikov V, Lagunin A, Filimonov D (2005) PASS: prediction of biological activity spectra for substances. In: Helma C (ed) Predictive toxicology. Taylor & Francis, New-York,
pp 459–478
71. Preston Mason R (2012) Pleiotropic effects of calcium channel blockers. Curr Hypertens Rep
14(4):293–303
72. Puzyn T, Leszczynski J, Cronin MTD (eds) (2010) Recent advances in QSAR studies: methods and applications. Challenges and advances in computational chemistry and physics,
vol 8. Springer Science+Business Media BV, Dordrecht
73. Radchenko EV, Palyulin VA, Zefirov NS (2008) Molecular field topology analysis in drug
design and virtual screening. In:Varnek A, Tropsha A (eds) Chemoinformatics approaches to
virtual screening. Royal Society of Chemistry, Cambridge, pp 150–181
74. Samokhina MP, Vassiliev PM, Chepljaeva NI (2007) QSAR-modeling of synergism between
active compounds of Gymnema sylvestris extract. In: Proceeding of the III Congress of
Pharmacologists of Russia “Pharmacology—practical health”, Saint Petersburg, 23–27 Sept
2007. Psycopharmacol biol narcol 7:1936
75. Samokhina MP, Vassiliev PM, Chepljaeva NI (2008) Experimental study of hypoglycemic
activity of Gymnema sylvestris extract and computer modeling of its components synergism.
In: Collection of scientific papers “Development, research and marketing of new pharmaceutical products”, PyatGFA, Pyatigorsk, p 490
76. Shanmugasundaram ER, Gopinath KL, Radha Shanmugasundaram K et al (1990) Possible
regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol 30(3):265–279
77. Siebert CD, HaÑ’nsicke A, Nagel T (2008) Stereochemical comparison of nebivolol with
other b-blockers. Chirality 20(2):103–109
78. Simonov AM, Kovalev GV, Anisimova VA et al (1996) Antiarrhythmic agent. Patent RU
2068261, 27 Oct 1996
79. Spasov AA, Chernikov MV, Vassiliev PM et al (2007) Histamine receptors (molecular biological and pharmacological aspects). Izd-vo VolgGMU, Volgograd
80. Spasov AA, Vassiliev PM, Grechko OY et al (2010) In silico screening of condensed azoles
derivatives with high pharmacological activity. In: Proceedings of the 2nd International congress EurasiaBio-2010, Moscow, 13–15 Apr 2010, pp 372–374